Updated August 15, 2024:
We continue to advance our transgenic soybean lines which exhibit partial nematode resistance. These lines show a 20-35% reduction in both of cyst/gm root and eggs/gm root compared to control plants. We are in the process of making crosses between most effective lines to stack the transgenes in one genetic background. We have also made crosses between our "Y23" line and Kansas adaptive lines that are either susceptible and moderately resistant to SCN. These lines have been backcrossed into the KS adapted genetic backgrounds and currently at the BC4 generation. We would like to test whether our transgenes have a synergistic effect with conventional genetic basis of SCN resistance. Last, we have produced lines in the transformation pipeline which have three transgenes stacked in one locus to simplify breeding efforts. These cultures are currently regenerating and we have identified three events which have the traits stacked which target multiple target genes.
For the fungus resistance objective, previously, we have identified several FvTox1 RNAi lines using gDNA PCR, and using RT-PCR, we identified RNAi lines with high levels of transgene transcript expression. We challenged these lines with Fusarium virguliforme Mont1 isoloate in collaboration with Dr. Rodrigo’s lab, but the assay was not successful as F. virguliforme failed to develop SDS symptoms even in the in the wild-type controls, suggesting that the infectivity assay needed to be optimized. Transgenic lines which were in the greenhouse in the winter have been harvested and we have increased our seeds for four events expressing the FV-Tox RNAi trait. We have also isolated an additional F. virguliforme strain from field collected material. We isolated DNA and cloned the FvTox gene from this strain to verify it has an identical FVTox sequence as the F. virguliforme Mont-1 isolate. As this is a Kansas isolate it will be more applicable our environment. The infectivity assay is currently being optimized with this isolate with wild type (non-transgenic ) plants. Additionally, we are developing additional lines with a stronger promoter to boost production of the RNAi molecules in the stems of the soybean.
For soybean stem borer objective our past field trials had mixed levels of tolerances. In our best event we observed a 66% reduction on the number of tunneling reaching the crown and only 8% of the plants having larva present in the stems and these larvae were dead. However, in most of our lines, larval tunneling and presence in the crown were highly variable. This was caused most likely by differences in transgene expression among the individual samples and the stem thickness of the transgenic lines. In the past six months we have focused on advancing three lines to homozygousity and crossing these lines into Kansas adapted lines. We have collected seeds from these lines and confirmed
This project is using tools of biotechnology to provide novel means of resistance or tolerance to diseases and insects. Specifically, 1) resistance to Soybean Cyst nematodes; 2) resistance to Sudden Death Syndrome (SDS) and: 3) resistance to the detectes stem borer. All of these projects are ongoing. We have created transgenic lines containing traits targeting the nematodes, pathogens, insects or drought stress, performed molecular analysis to identify lines which are stably express the traits, and advance these lines to homozygosity or bred these lines into Kansas adapted lines. We have good evidence that particular targets like our Y25 transgenic lines for nematode resistance and a couple lines expressing traits for stem borer resistance are providing increased levels of resistance. We also have developed soybean lines that have the potential for resistance to Sudden death syndrome. Additional assays are needed as well as a more complete molecular analysis.